Branched Stent Grafts Market Statistics
The global branched stent grafts market was valued worth USD 0.28bn in 2021 and is projected to be valued at USD 0.47bn by 2028, growing at a CAGR of 8.0%.
The Branched Stent Grafts market has grown extensively during the past few years. This is due to the rise in the incidence of coronary artery diseases. Moreover, the growing geriatric population and the rising prevalence of hypertension are some of the other drivers of the growth of the Branched Stent Grafts market.
Endovascular Aortic Aneurysm Repair to Drive the Branched Stent Grafts Market:
The growth of the Branched Stent Grafts market can be attributed to the rise in the prevalence of coronary artery diseases and diseases such as an abdominal aortic aneurysm. The endovascular Aortic Aneurysm Repair system is gaining popularity in treatment procedures. EVAR is preferred the most because it is a minimally invasive procedure where an expandable stent-graft is placed within the aorta to avoid surgery directly on the aorta. All these years, the stent graft design involved metallic stent frames to support the fabric. However, recently, polymer-based technology has been recommended as an alternative to fix abdominal aortic aneurysms (AAA). There are two categories under polymer-based technology- one is Endovascular Aneurysm Sealing (EVAS), a polymer filled end bags with Nellix Stent Grafts. The second one is EVAR, a polymer-based neck sealing device which is also known as an Ovation stent graft. The first category of end bags filled with polymer could not be successful however, the EVAR method to create circumferential sealing of the aneurysmal has established itself as safe and effective, thus leading to the expansion of the global branched stent grafts market.
Geriatric Population to Boost Demand
The geriatric population with coronary artery disease and the rise in the prevalence of hypertension is leading to growth opportunities for the branched stent market. According to data published by the Centre for Disease Control (CDC), 17% of elderly above the age of 65 have been reported to have coronary heart disease (CHD). 10. 9% of adults ageing 45 and above reported coronary heart diseases. The high volume of CHD among the elderly population is expected to create growth potential for the branched stent grafts market over the forecast years.
The high cost associated with the use of metallic stent grafts and the poor durability of these stent grafts are some of the challenges faced by the manufacturers of branched stent grafts and this could hinder the market during the forecast years.
However, rapidly growing vascular surgeries are projected to nudge the market to grow in the coming years.
| Data Points | Market Insights |
| Market Value 20201 | US$ 0.28Billion |
| Market Value 2028 | US$ 0.47Billion |
| Market Growth Rate 2021-2028 | 8.0% |
| Top Regional Market | North America |
| Key Players | Medtronic, Biotronik, Alvimedica, Abbott, Cook Medical Eucatech AG, Merit Medical Systems, Endocor GmbH |
| Segment | Product Type – (Iliac Stent, others), Applications (EVAR) |
Demand for Biocompatible Stents to Drive Iliac Segment
On the basis of product types, the branched stent grafts market is segmented into Sutures, Wire and Mesh, and others. Among these types, wire and mesh types is anticipated to hold a larger share in the market. Wire and mesh type is further segmented into Iliac, the demand for biocompatible stent grafts that have a lifespan of at least 5 years. Moreover, this segment is expected to grow exponentially during the forecast period owing to the evolution of new technologies in this field. Advancements in medical technology are helping to provide better diagnostic and therapeutic treatments for various diseases. This, in turn, is helping to lower mortality rates, leading to the growth of this segment in the global branched stent grafts market.
The Sutures segment has grown extensively during the past few years. This is due to the rise in the incidence of coronary artery diseases, will continue to grow in the future as well.
Based on application, the global branched stent market is segmented into EVAR, which is further segmented into FEVAR, Chimney, and Others. Among all these, the chimney EVAR is likely to register the highest growth in the coming years due to increasing demand for EVAR which is a minimally invasive procedure.
Strong Presence of Prominent Market Players to Hegemonize the Branched Stent Grafts Market
The North America Branched Stent Grafts market is projected to hold the largest share in the branched stent grafts market during the forecast period. The growth can be attributed to the strong presence of key players in the region along with technologically advanced health infrastructure. The increasing prevalence of coronary artery diseases and the rising number of geriatric populations in North America have also been driving the growth of this market. Europe is another promising region for the Branched Stent Grafts market, despite tough competition from Asia-Pacific countries.
Asia Pacific region is the largest market for Branched Stent Grafts. One of the reasons for this is the high incidence of coronary artery diseases in this region. Further, rising medical tourism and increasing spending on healthcare are some of the other drivers that could bring growth opportunities in the region.
The European Branched Stent Grafts market is expected to grow rapidly in the coming years due to the rise in the incidence of coronary artery diseases, rising geriatric population, and increase in cases of hypertension. Further, the high cost associated with metallic stent grafts and poor durability are some of the factors that are driving the growth of the global branched stent grafts market.
Competitive Landscape
The market is highly fragmented and competitive in nature with a strong presence of dominant players of the market.
Recent Developments:
In April 2022, Medtronic and GE Healthcare have decided to come together to cater to the growing need for outpatient care through Ambulatory Surgery Centers (ASCs) and Office-Based Labs (OBLs).
This collaboration aims at providing excellent patient care owing to the predicted increase in outpatients undergoing cardiology and vascular procedures in the forthcoming years.
In March 2022, Biotronik introduced a Biotronik patient app for patients with a cardiac device. The mobile app will benefit both clinicians and patients in tracking health status and records. This app simplifies the process and saves time for both, patients and clinicians. With the help of this app the patients can track the battery and telemonitoring status themselves.
In 2021, Alvimedica announced the CE mark approval for its Fluydo™ NC, a new PTCA NON-COMPLIANT Balloon Catheter, which is designed to cross and efficiently dilate the challenging and difficult coronary lesions.
The key players in the global branched stent grafts involve-
- Cardinal Health (Cordis)
- Boston Scientific Corp.
- Terumo Corp.
- Medtronic
- Biotronik
- Alvimedica
- Abbott
- Cook Medical
- Eucatech AG
- Merit Medical Systems
- Endocor GmbH
Type Outlook (Revenue, USD Billion)
- Sutures
- Wire & Mesh
- Iliac Stent
- Others
Application Outlook (Revenue, USD Billion)
- EVAR
- FEVAR
- Chimney
- Others
Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Greece
- The Netherlands
Asia Pacific
- Japan
- China
- India
Latin America
- Mexico
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Frequently Asked Questions
What is the size of the global branched stent grafts market?
The branched stent-grafts market would grow at a CAGR of 8.0% and is anticipated to be valued at USD 0.47bn by 2028.
What is the study period for the branched stent grafts market?
The forecast period for the global branched stent grafts market is between 2021 to 2028
What are the growth drivers for the market?
Rising incidences of coronary artery diseases are expected to drive the market during the forecast period.
Which application segment would account for the highest growth?
The endovascular Aortic Aneurysm Repair application segment is anticipated to account for the highest growth.
Which region will dominate the global stent grafts market?
North America is projected to dominate the regional segment, owing to presence of key players in the region.
Table Of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Branched Stent Grafts Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Branched Stent Grafts Market Analysis 2017-2021 and Forecast 2022-2032, By Type Outlook
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Type Outlook, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Type Outlook, 2022-2032
5.3.1. Sutures
5.3.2. Wire & Mesh
5.3.2.1. Iliac Stent
5.3.3. Others
5.4. Y-o-Y Growth Trend Analysis By Type Outlook, 2017-2021
5.5. Absolute $ Opportunity Analysis By Type Outlook, 2022-2032
6. Global Branched Stent Grafts Market Analysis 2017-2021 and Forecast 2022-2032, By Application Outlook
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application Outlook, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application Outlook, 2022-2032
6.3.1. EVAR
6.3.1.1. FEVAR
6.3.1.2. Chimney
6.3.1.3. Others
6.4. Y-o-Y Growth Trend Analysis By Application Outlook, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application Outlook, 2022-2032
7. Global Branched Stent Grafts Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. East Asia
7.3.5. South Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Branched Stent Grafts Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Type Outlook
8.2.3. By Application Outlook
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Type Outlook
8.3.3. By Application Outlook
8.4. Key Takeaways
9. Latin America Branched Stent Grafts Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Argentina
9.2.1.4. Chile
9.2.1.5. Peru
9.2.1.6. Rest of Latin America
9.2.2. By Type Outlook
9.2.3. By Application Outlook
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type Outlook
9.3.3. By Application Outlook
9.4. Key Takeaways
10. Europe Branched Stent Grafts Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. U.K.
10.2.1.5. Spain
10.2.1.6. Russia
10.2.1.7. BENELUX
10.2.1.8. Rest of Europe
10.2.2. By Type Outlook
10.2.3. By Application Outlook
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type Outlook
10.3.3. By Application Outlook
10.4. Key Takeaways
11. East Asia Branched Stent Grafts Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.2. By Type Outlook
11.2.3. By Application Outlook
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type Outlook
11.3.3. By Application Outlook
11.4. Key Takeaways
12. South Asia Branched Stent Grafts Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Thailand
12.2.1.3. Malaysia
12.2.1.4. Indonesia
12.2.1.5. Rest of South Asia
12.2.2. By Type Outlook
12.2.3. By Application Outlook
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type Outlook
12.3.3. By Application Outlook
12.4. Key Takeaways
13. Oceania Branched Stent Grafts Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Type Outlook
13.2.3. By Application Outlook
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type Outlook
13.3.3. By Application Outlook
13.4. Key Takeaways
14. MEA Branched Stent Grafts Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC
14.2.1.2. Rest of MEA
14.2.2. By Type Outlook
14.2.3. By Application Outlook
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type Outlook
14.3.3. By Application Outlook
14.4. Key Takeaways
15. Key Countries Branched Stent Grafts Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Type Outlook
15.1.2.2. By Application Outlook
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Type Outlook
15.2.2.2. By Application Outlook
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Type Outlook
15.3.2.2. By Application Outlook
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Type Outlook
15.4.2.2. By Application Outlook
15.5. Argentina
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Type Outlook
15.5.2.2. By Application Outlook
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Type Outlook
16.3.3. By Application Outlook
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Cardinal Health (Cordis)
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Boston Scientific Corp.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Terumo Corp.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Medtronic
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Biotronik
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Alvimedica
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Abbott
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Cook Medical
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Eucatech AG
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Merit Medical Systems
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Endocor GmbH
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Request Free Sample
